CCXI
ChemoCentryx Inc
Price:  
51.99 
USD
Volume:  
2,480,364.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CCXI WACC - Weighted Average Cost of Capital

The WACC of ChemoCentryx Inc (CCXI) is 8.6%.

The Cost of Equity of ChemoCentryx Inc (CCXI) is 8.60%.
The Cost of Debt of ChemoCentryx Inc (CCXI) is 8.85%.

Range Selected
Cost of equity 7.30% - 9.90% 8.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 10.70% 8.85%
WACC 7.3% - 9.9% 8.6%
WACC

CCXI WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.63 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 10.70%
After-tax WACC 7.3% 9.9%
Selected WACC 8.6%